TScan Therapeutics, Inc. Depreciation in USD from 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
TScan Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to Q1 2025.
  • TScan Therapeutics, Inc. Depreciation for the quarter ending March 31, 2025 was $678K, a 45.9% decline year-over-year.
  • TScan Therapeutics, Inc. annual Depreciation for 2024 was $4.11M, a 23.4% decline from 2023.
  • TScan Therapeutics, Inc. annual Depreciation for 2023 was $5.36M, a 4.36% increase from 2022.
  • TScan Therapeutics, Inc. annual Depreciation for 2022 was $5.14M, a 54.4% increase from 2021.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)

TScan Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $678K -$576K -45.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $1.25M -$245K -16.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $1.5M +$304K +25.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q1 2022 $1.2M +$726K +155% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q1 2021 $469K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12

TScan Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.11M -$1.25M -23.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-05
2023 $5.36M +$224K +4.36% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-05
2022 $5.14M +$1.81M +54.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $3.33M +$2.1M +171% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $1.23M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.